An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients

BACKGROUND: Umeclidinium/vilanterol (UMEC/VI; ANORO ELLIPTA, GSK) is a commonly used dual bronchodilator. This study evaluated the safety and effectiveness of UMEC/VI in Korean patients with chronic obstructive pulmonary disease (COPD) over a 6-year period. METHODS: This was an open-label, multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Eun-Yeong, Cho, Jung-Eun, Lee, Eun-Bin, Yoo, Seung Soo, Chang, Jung Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816489/
https://www.ncbi.nlm.nih.gov/pubmed/36437604
http://dx.doi.org/10.4046/trd.2022.0055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816489/
https://www.ncbi.nlm.nih.gov/pubmed/36437604
http://dx.doi.org/10.4046/trd.2022.0055

Ejemplares similares